| abstract |
Disclosed is a therapeutic and prophylactic agent for diabetes and hypoglycemia, including insulin-induced hypoglycemia. A peptide composed of 38 amino acids, in which amylin, which is a major protein component of amyloid found in pancreatic islets of type 2 diabetic patients, is partially modified with amino acids to form intramolecular bridges and the C-terminal is modified. Sex agonist analog. A method of treating diabetes and other insulin demand symptoms and a method of treating hypoglycemia using the related pharmaceutical composition. [Selection figure] None |